Podcast: Michael Kamarck of Merck BioVentures on Opportunities in Biosimilars - - BioPharm International

ADVERTISEMENT

Podcast: Michael Kamarck of Merck BioVentures on Opportunities in Biosimilars


Michael Kamarck, President, Merck BioVentures Opportunities in Biosimilars

With the approval of an abbreviated pathway by which biosimilars may be authorized in the US, the attention is now shifting to the challenges in store for innovator companies in defending their patents and the generics companies in challenging them. In this interview, Michael Kamarck, president of Merck BioVentures and senior vice president, vaccines and biologics manufacturing, discusses the opportunities and challenges in biosimilars.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
FDA Practices Discourage Biologic Market Competition, Says PCMA White Paper
November 19, 2014
FDA Approves Lemtrada for the Treatment of Multiple Sclerosis
November 17, 2014
Roche's Avastin Gains Ovarian Cancer Indication
November 17, 2014
Author Guidelines

Click here